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A study to compare disease-specific quality of life
with clinical anatomical and hemodynamic
assessments in patients with varicose veins
Amanda C. Shepherd, MBBS, Manj S. Gohel, MD, FRCS, Chung S. Lim, MBBS, and
Alun H. Davies, DM, FRCS, London, United Kingdom
Objective: The wide variety of outcome measures to evaluate patients with varicose veins poses significant difficulties when
comparing clinical trials. In addition, the relationship between different outcomemeasures is poorly understood. The aim
of this study was to compare anatomical, hemodynamic, and clinical outcomes with disease-specific quality-of-life tools
in patients undergoing treatment for varicose veins.
Methods: Patients undergoing treatment for symptomatic veins in a single unit were studied. Assessments included duplex
ultrasonography, digital photoplethysmography, evaluation of Venous Clinical Severity Scores and CEAP scores, generic
(Short Form 12 [SF12]) and disease-specific (Aberdeen Varicose Vein Questionnaire [AVVQ], and Specific Quality-of-
life and Outcome Response-Venous [SQOR-V]) questionnaires. Patients were reviewed at 6 weeks when hemodynamic,
clinical, and quality-of-life assessments were repeated. The relationships between these outcomes were assessed.
Results: The AVVQ showed a strong positive correlation with the SQOR-V (Spearman coefficient 0.702; P < .001) and
weaker, but significant correlations with the SF12 physical andmental component scores and the Venous Clinical Severity
Score (VCSS) (P < .001, P  .019, and P < .001, respectively, Spearman correlation). No correlations were observed
between the AVVQ and photoplethysmography results (Spearman coefficient 0.042; P  .606), and weak correlations
were observed with the AVVQ and anatomical reflux. At 6 weeks, functional, clinical, and hemodynamic measurements
were all responsive to changes following interventions; however, correlations observed between changes in disease-specific
quality-of-life and generic, clinical, and hemodynamic outcomes were weak.
Conclusions: Both the AVVQ and SQOR-V questionnaire are sensitive and responsive disease-specific questionnaires,
which correlate with generic and clinical outcomes to some extent. Anatomical and hemodynamic measurements
correlated poorly with functional outcomes both preoperatively and following interventions. ( J Vasc Surg 2011;53:
374-82.)
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iIn the last decade, there have been significant changes
in the management of varicose veins, with a move away
from traditional surgery toward endovenous ablation tech-
niques.1-3 However, the evaluation of outcomes in venous
disease after intervention is inconsistent.4 In comparison to
peripheral arterial disease, where objective tools are avail-
able for the measurement of disease severity and disease
change (such as ankle-brachial pressure indexes), the assess-
ment and classification of venous disease is less clear. Severe
morbidity and complications occur rarely, and there is an
absence of simple objective measures of disease severity or a
tool to allow assessment of improvements following inter-
vention, making evaluation of outcomes very difficult.
Early studies into the efficacy of endovenous ablation tech-
niques and traditional surgery have concentrated primarily
on occlusion rates, clinical recurrence, and hemodynamic
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374unction,5-7 as these are outcomes that can be objectively
easured. However, these surrogate end points do not
ecessarily reflect the patients’ experience or the clinical or
unctional outcome.8 The optimal outcome measure fol-
owing treatment of superficial venous reflux is contentious,
nd there are a wide range of investigations, from surrogate
nd points such as occlusion and hemodynamic improve-
ent to clinical and functional improvements, with numer-
us quality-of-life questionnaires available, each with their
wn advantages and disadvantages.9
Although an assessment of anatomical success is impor-
ant to determine the effectiveness of new procedures,
tandard laser and radiofrequency ablation procedures have
een shown to consistently produce occlusion rates supe-
ior to that of traditional surgery or foam sclerotherapy10
nd occlusion rates, therefore, have limited value in the
omparison of outcomes for the latest treatment modali-
ies. Similarly, hemodynamic success has been shown to be
seful in patients with venous ulceration;11 however, its
pplication is questionable in patients with uncomplicated
isease as an outcome measure. In 2007, the American
enous Forum published recommended reporting stan-
ards advocating the use of disease-specific patient-
eported outcome measures, in combination with a mea-
urement of generic quality-of-life and clinical assessment
n all clinical trials evaluating the use of endovenous thera-
ies,12 which were revised in 2009.13
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Volume 53, Number 2 Shepherd et al 375With patient preference becoming increasingly impor-
tant in the management of varicose veins, patient-reported
outcomes are proposed to provide the most accurate assess-
ment of disease severity and change following intervention
and are becoming increasingly popular, in the hope that a
patient-centered approach will lead to improvements in the
quality of healthcare.14 At present, a wide variety of out-
come measures are in use throughout the world. The
relationship between these outcome measures is important
to consider if comparisons between studies and results are
to be made, but, to date the relationship between quality of
life and other outcome measures is poorly understood.
The aim of this study was to evaluate the relationship
between disease-specific quality of life and clinical, hemo-
dynamic, and anatomical measures and to investigate the
degree to which they reflect changes in quality of life
following intervention.
METHODS
Study population and setting
Adult patients who had been placed on a waiting list for
endovenous thermal ablation of symptomatic varicose veins
in a London teaching hospital were invited to participate in
the study. All patients had previously undergone color
duplex ultrasonography (Philips iU22; Philips Ultrasound,
Bothell, Wash) by an accredited vascular scientist, and all
patients with truncal venous reflux of 0.5 seconds with a
vein diameter of 3 mm were considered candidates for
thermal ablation. Those who were unsuitable were offered
open surgery. Patients with recurrent disease and deep
venous reflux were included in the study.
Recruitment and treatment allocation
Patients were recruited over an 18-month period be-
tween January 2008 and July 2009. Some of the patients
included were participants in the VNUS ClosureFAST
Ablation versus Laser for Varicose Veins (VALVV) Trial15
and were, therefore, randomized to their treatment alloca-
Fig 1. Outcome assessment in venous disease. AVVQ
Quality of life and Oution. For other patients, treatment choice was made on the tasis of patient preference or equipment availability. Ethical
pproval for the trial was granted by Charing Cross Re-
earch Ethics Committee. The trial was registered with
urrent controlled trials ISRCTN66818013.
reatments performed
All participants were treated with VNUS ClosureFAST
adiofrequency ablation (VNUS Medical Technologies,
an Francisco, Calif), Radiofrequency Induced Thermo
herapy (RFITT; Celon AGMedical Instruments, Teltow,
ermany), or endovenous laser ablation with a 980-nm or
470-nm laser Biolitec (Ceram Optec GmbH, Bonn, Ger-
any). All procedures were performed under general anes-
hesia and tumescent anesthesia with concomitant phlebec-
omies under ultrasound guidance. Following all
rocedures, the operating surgeon performed a scan of the
reated truncal vein and assessed the patency of the deep
eins. Otherwise, duplex ultrasonography was not per-
ormed postintervention unless patients presented with
ymptoms of deep venous thrombosis.
utcomes assessed
Outcomes were categorized as anatomical, hemody-
amic, clinical, and functional (Fig 1).
Anatomical. Duplex scans were performed by an ac-
redited vascular scientist, and reflux was defined as retro-
rade flow of 0.5 seconds. Based on the findings of the
uplex ultrasonography, patients were categorized as hav-
ng unilateral or bilateral disease, and the presence or
bsence of deep vein incompetence was also recorded.
atients were also scored according to the Venous Segmen-
al Disease Score (VSDS)16 for reflux for each leg.
Hemodynamic. Venous refill times (VRTs) were as-
essed using a digital photoplethysmography (ELCAT Va-
oquant VQ1000; ELCAT Medical Systems, Wolfran-
hausen, Germany) with the patient in a seated position on
he morning of treatment. An average of two reading were
rdeen Varicose Vein Questionnaire; SQOR-V, Specific
e Response-Venous., Abeaken, and a third was taken if the first two readings varied
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February 2011376 Shepherd et alby more than 10%. VRTs of 30 seconds were considered
normal.
Clinical. The Clinical Etiologic, Anatomical and
Pathophysiological (CEAP) grade and the Venous Clinical
Severity Score (VCSS)16 were recorded by a clinician on the
morning of treatment.
Functional. Prior to procedures, all patients were
asked to complete two disease-specific questionnaires. The
Aberdeen Varicose Vein Questionnaire17,18 contains 13
multiple-choice questions relating to signs and symptoms
of venous disease and their functional impact. A score of 0
to 100 is calculated for each patient (0 no disease, 100
severe disease), and full details of the questionnaire are
available in the original article.17 The Specific Quality of
Life and Outcome Response-Venous (SQOR-V) disease-
specific questionnaire consists of 46 multiple-choice ques-
tions divided into five domains including physical discom-
fort, appearance, restriction in movements, risk, and threat
to health and emotional problems. An overall score per
patient is derived with a minimum of 20 (no disease) and a
maximum of 100 (severe disease). Physical and mental
component scores can also be calculated for each patient.
Details of the questionnaire and scoring algorithm are
available in the original article.19 Patients also completed
the generic short form 12 (SF12) questionnaire, which
consisting of 12 questions relating to general physical and
mental health, and a separate physical component score
(PCS) and mental component score (MCS) is generated.
The SF12 was scored with software purchased from quality
metric (Quality Metric, Lincoln, RI).
Follow-up
All patients were invited for follow-up at 6 weeks
postprocedure, when they were invited to complete the
questionnaires again. In addition, a clinical assessment of
disease severity and venous refill times were recorded by the
reviewing clinician.
Statistical analysis
Outcomes were scored per patient (Aberdeen Varicose
Vein Questionnaire [AVVQ], SQOR-V, and SF12) or per
leg (VRT, VSDS). VCSS and CEAP scores are recorded per
leg and for comparisons with Quality of Life (QoL), the
score of the worst leg was used. Where disease-specific
quality of life was compared with VRTs or VSDS scores,
patients with bilateral disease were excluded from the anal-
ysis.
All statistical analysis was performed using SPSS version
17.0 (SPSS, Inc, Chicago, Ill). Correlations between out-
comes were assessed using Spearman’s correlation for non-
parametric data. Groups were compared using Mann-
Whitney U and Kruskal-Wallis tests for nonparametric data as
appropriate. The responsiveness of outcome measures was
assessed using the standardized response mean (SRM),
calculated by dividing the mean change in score by the
standard deviation of the change. The higher the SRM, the wore sensitive the tool to clinical change, with SRMs of
.2, 0.5, and 0.8 representing small, moderate, or large
hanges, respectively.20 To avoid potential errors intro-
uced by multiple testing, P values of .01 or less were
onsidered significant.
ESULTS
atient flow and demographics
Over a period of 18 months between January 2008 and
uly 2009, preoperative data were collected for 317 adult
atients (female n  227, male n  90), of mean (SD) age
8.87 (14.49) years (range, 18-87 years). The recruitment
nd follow-up of patients in the study is summarized in Fig
. A total of 252/317 (80%) of patients had primary
aricose veins and 65 had recurrent veins. Color duplex
canning confirmed that 191 patients (60%) had unilateral
isease, 126 had bilateral disease, and 45 (14%) also had
eep venous incompetence. Of the 443 legs studied, 322
73%) had great saphenous vein incompetence alone, 31
7%) had SSV incompetence alone, and 90 (20%) had more
han one refluxing vein. Baseline CEAP clinical scores for
he group were C2 (n  131), C3 (n  88), C4 (n  79),
5 (n  8), and C6 (n  11).
No significant difference was observed in any baseline
cores between patients with primary and recurrent disease
AVVQ (P  .163), SQOR-V (P  .171), SF12PCS (P 
08), SF12MCS (P .373), VCSS (P .038), VSDS (P
386), and VRT (P  .435) Mann-Whitney U test].
ssessment of the severity of venous disease
Relationship between baseline AVVQ, SQOR-V,
nd SF12 questionnaires. The AVVQ showed a strong
ositive correlation with the SQOR-V disease-specific
uestionnaire (Fig 3) (Spearman coefficient 0.702; P 
001) and a weak, but significant correlation with the
hysical component of the generic SF12 questionnaire
Spearman coefficient 0.308; P  .001). Correlation
ith the mental component score was very weak and of
orderline significance only (Spearman coefficient0.162;
 .007).
The physical and mental component breakdown scores
f the SQOR-V showed a weak correlation with the SF12
CS but not the MCS (Spearman coefficient 0.310; P 
001-PCS and Spearman coefficient 0.143; P  .019-
CS). The AVVQ is the most widely used and well-
alidated disease-specific questionnaire and is, therefore,
sed as the primary comparator for clinical, hemodynamic,
nd anatomical data in this study.
Relationship between baseline AVVQ, SQOR-V,
nd CEAP clinical score. The AVVQ correlated with
ncreasing CEAP grade (P  .001 analysis of variance
ANOVA]) (Fig. 4, a), patients with C5/6 disease had
ignificantly higher AVVQ scores (median, interquartile
ange [IQR]) [36.75 (18.42-45.15) than those who had
3/4 disease, (17.68 [13.15-25.82]) (P  .001 Mann-
hitney U) who had significantly worse scores than those
ith C2 disease (15.20 ([11.08, 22.59]) (P .001 Mann-
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Volume 53, Number 2 Shepherd et al 377Whitney U). Interestingly, SQOR-V scores did not corre-
late with CEAP scores, as patients with C4 disease had
better scores than those with C3 disease (P  .093
ANOVA) (Fig 4, b).
Relationship between baseline AVVQ, SQOR-V,
and VCSS. AVVQ scores also correlated positively with
preoperative VCSS scores (Spearman coefficient 0.439; P
.001). SQOR-V scores also showed a weak correlation with
Fig 2. Consort diagram. EVLA, Endoveno
Fig 3. Relationship between the Aberdeen Varicose Vein Ques-
tionnaire (AVVQ) and the Specific Quality of life and Outcome
Response-Venous (SQOR-V).VCSS scores (Spearman coefficient 0.197; P  .001). aRelationship between baseline AVVQ, SQOR-V,
nd VRTs. The relationship between disease-specific
uality-of-life and venous refill times was evaluated, but no
orrelation was observed between the venous refill time in
atients with unilateral disease and either AVVQ or
QOR-V tools (Spearman coefficients 0.042 and 0.043;
 .606 and P  .065, respectively).
The relationship of baseline AVVQ and SQOR-V
n patients with deep venous incompetence. Patients
ith deep venous incompetence appeared to have a worse
uality of life according to the AVVQ (median [IQR])
8.68 (13.12-29.99) vs 16.62 (11.58-23.99) (P  .047
ann-Whitney U), although SQOR-V scores were not
ignificantly different in patients with deep venous incom-
etence (P  .640 Mann-Whitney U).
The relationship of AVVQ, SQOR-V, and VSDS. The
VVQ showed a weak correlation with VSDS scores when
cores for both legs were added (Spearman coefficient
.230; P  .001) but did not correlate with AVVQ scores
hen patients with unilateral disease alone were evaluated
P  .328). The SQOR-V did not correlate with VSDS
cores when scores were added in patients with bilateral
isease (Spearman coefficient 0.124; P  .036) or when
atients with unilateral disease alone were analyzed (Spear-
an coefficient 0.014; P  .856).
ssessment of responsiveness to changes following
ntervention
Patients were invited to attend follow-up appointments at
weeks following intervention and follow-up data were avail-
er ablation; RFA, radiofrequency ablation.ble from 225/316 (71%) patients. Quality-of-life question-
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February 2011378 Shepherd et alnaires were returned for 214 (68%) patients. No significant
difference in disease severity or pattern of reflux was observed
in patients whodid not attend follow-up comparedwith those
who did, evaluated using the baseline VCSS (P  .591) and
VSDS (P  .137) Mann-Whitney U test. Overall, patient
quality of life, clinical, and hemodynamic scores improved at 6
weeks in comparison to baseline scores (Table).
Relationship between changes in AVVQ, SQOR-V,
and SF12. The relationship between improvements in
quality of life postprocedure is evaluated as the percentage
change in the postprocedure scores in comparison to those
at baseline.
AVVQ scores postprocedure showed a positive corre-
lation with percentage change in postprocedural SQOR-V
scores at 6 weeks, Spearman coefficient 0.492; P  .001
(Fig 5).
Patients who experienced large improvements in
AVVQ scores generally experienced similar improvements
in SQOR-V scores, and those who experienced a worsening
of AVVQ scores also reported worse SQOR-V scores.
However, a small number of patients had worsening AVVQ
scores with improvements in the SQOR-V and vice versa.
Very weak correlations observed between changes in
AVVQ scores and changes in the SF12 MCS scores at 6
weeks were of borderline significance (Spearman coefficient
0.196; P .008), but no correlation was seen between the
PCS and the AVVQ (Spearman coefficient 0.159; P 
Fig 4. Relationship between the Aberdeen Varicose
Outcome Response-Venous (SQOR-V), and Clinical Et
score. ANOVA, Analysis of variance.
Table. Pre- and postprocedure quality of life, clinical score
AVVQ SQOR-V SF1
Baseline 17.01 (12.14-24.64) 45.60 (36.54-57.17) 49.64 (42
6 week 9.69 (5.50-16.68) 33.53 (25.64-42.11) 53.73 (46
P valuea P  .001 P  .001 P 
AVVQ, Aberdeen Varicose Vein Questionnaire; IQR, interquartile range; S
physical component score; SQOR-V, Specific Quality of Life and Outcome R
time in seconds.
Figures presented as median (IQR).
aWilcoxon Rank..032). 0Relationship between changes in AVVQ, SQOR-V,
nd VCSS. Percentage changes in the AVVQ also showed
weak correlation with percentage changes in the VCSS
Spearman coefficient 0.299; P .001); however, percent-
ge changes with the SQOR-V did not correlate with
ercentage changes in the VCSS (Spearman coefficient
Questionnaire (AVVQ), Specific Quality of life and
ic, Anatomical and Pathophysiological (CEAP) clinical
d venous refill times
S SF12 MCS VCSS VRT
55.24) 50.97 (41.60-56.47) 4 (4-6) 19.33 (11.00-25.50)
56.93) 53.81 (645.90-57.16) 1 (0-2) 25.73 (17.00-33.00)
P  .004 P  .001 P  .001
CS, Short Form 12 mental component score; SF12 PCS, Short Form 12
se-Venous; VCSS, Venous Clinical Severity Score; VRT,mean venous refill
ig 5. Relationship between the percentage change in Aberdeen
aricose Vein Questionnaire (AVVQ) and percentage change in
pecific Quality of life and Outcome Response-Venous (SQOR-V)
cores at 6 weeks.Vein
iologs, an
2 PC
.48-
.70-
.001
F12 M
espon.062; P  .401).
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and VRTs. Changes in venous refill times at 6 weeks did
not correspond to changes in AVVQ (Spearman coefficient
0.067; P  .587) or with SQOR-V scores (P  .437;
Spearman coefficient 0.073) in patients with unilateral
disease.
Responsiveness of the SQOR-V and AVVQ ques-
tionnaire. AVVQ scores pre- and postintervention corre-
late with preoperative CEAP scores (P  .001 ANOVA)
and patients across all degrees of clinical severity appear to
gain significant improvement in their scores (P  .001 for
C2/3/4 patients and P  .002 C5/6 patients; P  0.002
Wilcoxon Rank). However, percentage changes in AVVQ
did not correlate with preoperative CEAP, as improve-
ments were similar in all classes (P  .965 ANOVA).
Results show that the SQOR-V questionnaire also appears
to show significant improvements in scores after interven-
tion for all degrees of severity (P  .001 C2/3/4 and P 
.004 C5/6 Wilcoxon Rank). However, preoperative
SQOR-V scores did not correlate with C4-C6 CEAP scores
(P  .093 ANOVA) or the percentage of improvement
postintervention (P  .602 ANOVA). The responsiveness
of the AVVQ and SQOR-V questionnaires was evaluated
using the SRM. SRMs confirmed that the AVVQ and the
SQOR-V were highly responsive to changes at 6 weeks
(SRMs 0. 897 and 0.870 for the AVVQ and SQOR-V,
respectively). SRMs have been calculated for patients ac-
cording to baseline clinical CEAP (Fig 6). When evaluating
Fig 6. Relationship between responsiveness of the Ab
Quality of life and Outcome Response-Venous (SQOR-
mean (S.D.). CEAP, Clinical, Etiologic, Anatomical andthe degree of change postprocedure, both questionnaires qppear to show similar degrees of improvement according
o the SRM. We were not able to demonstrate an increased
ensitivity for the SQOR-V in patients with C2 and C3
isease.
ISCUSSION
This study demonstrated that there is poor correlation
etween disease-specific quality of life and other outcome
easures used to evaluate varicose veins. As demonstrated
reviously, AVVQ scores did correlate significantly with
linical CEAP scores,21,22 but only weak correlations were
bserved between AVVQ and preoperative generic quality-
f-life (SF12) or VCSS scores. Correlations between the
F12, CEAP, and VCSS were very weak and of borderline
ignificance both pre- and postoperatively, and no correla-
ions were observed between the SF12 and VRTs. Results
bserved with the AVVQ and VCSS scores in this study
ere similar to those reported in other series and in recent
andomized clinical trials assessing endovenous thermal
blation modalities, with comparable improvements in
cores with other studies.23,24 No correlations were ob-
erved between AVVQ scores and venous refill times, either
reoperatively or following intervention. The adjustment
or patients with primary versus recurrent varicose veins did
ot alter the significance of the correlations. Although
ome smaller studies have shown correlations of VRTs with
reoperative quality of life, they have found no correlation
n changes in VRT with either generic or disease-specific
n Varicose Vein Questionnaire (AVVQ) and Specific
cording to CEAP clinical class. Scores are presented as
ophysiological; SRM, standardized response mean.erdee
V), acuality of life following intervention,25 suggesting that
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tool in patients with uncomplicated venous disease. Weak
correlations were seen between AVVQ scores and anatom-
ical reflux according to VSDS scores, further supporting the
theory that the presence of anatomical reflux does not
necessarily correlate with functional impairment or clinical
disease.26,27 These findings suggest that anatomical reflux
should not be relied upon in isolation as an outcome
measure in routine practice.
Explanations for the correlations observed may, in part,
be due to the relatively small number of patients studied,
and also that some hemodynamic factors were beyond the
scope of this study and not assessed. Indeed, previous
studies have suggested that higher venous reflux velocities
are associated with a worse clinical outcome following
saphenous vein ablation,28 which were not recorded in this
study. They may also represent patients in whom symptoms
reported were unrelated to an underlying venous cause.
However, due to the difficulties in correlating venous reflux
with symptomatogy,26,29 this is extremely difficult to as-
sess.
In contrast, a strong correlation was observed between
the two disease-specific quality-of-life questionnaires eval-
uated, stronger than that seen with the SF12, supporting
the use of the SQOR-V as a valid and responsive disease-
specific questionnaire. Interestingly, in the majority of pa-
tients, changes in postprocedure AVVQ scores correlated
with the SQOR-V, but a number of patients experienced
improvement in one score, with worsening of the other. It
is possible that this may reflect different sensitivities of the
questionnaires applied to different patient groups, or ran-
dom errors in question responses. Because of the very small
number of cases this applied to, the authors were unable to
evaluate this further. The SQOR-V questionnaire was spe-
cifically designed to allow more sensitive evaluation of the
functional impact of venous disease in patients in CEAP
classes C1-C3. The results from this study were able to
support the use of the SQOR-V in this patient group,
although were unable to demonstrate any superiority over
the AVVQ. However, the study did not make a full assess-
ment of the effectiveness of the SQOR-V questionnaire due
to the absence of patients with C1 disease alone, for whom
referrals to secondary care are restricted by the United
Kingdom state health care system.
In patients with skin changes and ulceration (C4-C6),
the SQOR-V questionnaire did not correlate with clinical
CEAP scores, a trend also observed by the original au-
thors.19 Differences in scores are likely to be due to the
differences in the design of the questionnaires. The
SQOR-V is based on patient reported symptoms and not
clinical signs, whereas the AVVQ attributes a heavier
weighting to the presence of skin changes and ulceration.
Despite this the SQOR-V remained highly responsive in all
patient groups, with responsiveness scores similar to the
AVVQ.
The choice of outcome measure in venous disease is
difficult and has been of great interest in recent years.30 The
VCSS is undoubtedly easy and quick to use and provides a pood assessment of disease severity, but offers no evalua-
ion of the impact of the disease state on the quality of
ife of the patient, which is of paramount importance.
uality-of-life questionnaires provide a more complete
ssessment of the disease state, and patient-reported
utcome measures (PROMs) have recently been intro-
uced in the United Kingdom for the assessment of
utcomes following a number of elective procedures
ncluding varicose veins. Prior to their introduction, an
xtensive review of the literature regarding existing pa-
ient-reported outcome questionnaires was commis-
ioned by the UK Department of Health and published
n 2005.31 At the time, two disease specific question-
aires specifically designed for use in varicose vein surgery
ere identified (the AVVQ and VEINES-QOL/Sym) and
ere deemed to have “acceptable evidence of reliability,
alidity, and responsiveness” to be considered for use by
he United Kingdom Department of Health.31 In addi-
ion, two other disease-specific questionnaires for use in
enous-related diseases were identified but not included in
he review as they were not designed for varicose vein
urgery. The AVVQ was eventually selected, as it was the
referred choice in surveyed clinicians, who were more
amiliar with its use and preferred it to the VEINES-QOL/
ym questionnaire.
The choice of outcome measure following intervention
or venous disease is clearly important, not only to evaluate
mprovement in individual patients, but also to allow a
omparison of treatment modalities in studies and clinical
rials. With huge heterogeneity in outcome measures used,
omparison of the results of different studies is difficult.4
urrent recommended reporting standards (published by
he American Venous Forum) advise the use of generic,
isease-specific, and clinical outcome measures for a com-
rehensive assessment.13 Duplex ultrasonography has been
n important tool in establishing the efficacy of endovenous
blation techniques, however, not all patients underwent
uplex scanning postoperatively in this study. The weak
orrelations observed between anatomical and functional
utcomes suggest that residual anatomical reflux in the
bsence of symptoms is unlikely to justify intervention, and
onsequently, routine duplex scanning is of questionable
alue and may not be a cost-effective use of scarce health-
are resources. The use of PROMs could potentially negate
he need for postoperative hemodynamic and anatomical
valuation in routine practice.
This study comprised a combination of randomized
nd nonrandomized patients and therefore differences in
reatment allocation. However, no significant differences in
utcomes were observed between the treatment groups at
weeks. As the aim of the study was to evaluate the
elationship between outcome assessment tools and not
he comparison of outcomes, this should not have affected
he results. This study was also unable to evaluate disease-
pecific quality-of-life questionnaires in patients who did
ot undergo intervention, as these patients are usually
anaged in primary care. The follow-up rate of 68% of
atients at 6 weeks despite reminder letters and telephone
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Volume 53, Number 2 Shepherd et al 381calls was disappointing, and a larger dropout rate was seen
in the nonrandomized patients. In this study, the evalu-
ation of digital photoplethysmography as an outcome
measure was difficult to correlate with quality of life;
however, in this instance, patients with bilateral disease
were excluded from the analysis, reducing the numbers,
which may have affected results. Overall, we believe that
this is an important assessment of the reliability and use
of different outcome measures in the assessment of ve-
nous disease, although to recommend specific tools in
preference to others, larger studies will undoubtedly be
required.
CONCLUSIONS
Evaluation of the severity of venous disease and the
optimal outcome measure remains controversial. The use
of a range of outcomes measures, including disease-specific
questionnaires is likely to be optimal and may replace
surrogate outcome measures in the future. International
consensus as to the most appropriate questionnaire to use
for a particular patient group would aid comparison be-
tween clinical studies, although at present, no such consen-
sus exists.
AUTHOR CONTRIBUTIONS
Conception and design: AS, MG, AD
Analysis and interpretation: AS, MG, CL, AD
Data collection: AS, CL
Writing the article: AS, MG, CL, AD
Critical revision of the article: AS, CL, MG, AD
Final approval of the article: AS, CL, MG, AD
Statistical analysis: AS, MG
Obtained funding: AS, CL
Overall responsibility: AD
REFERENCES
1. Edwards AG, Baynham S, Lees T, Mitchell DC. Management of vari-
cose veins: a survey of current practice by members of the Vascular
Society of Great Britain and Ireland. Ann R Coll Surg Engl 2009;91:
77-80.
2. Shepherd AC, GohelMS, HamishM, LimCS, Davies AH. Endovenous
treatments for varicose veins–over-taking or over-rated? Phlebology
2010;25:38-43.
3. Winterborn RJ, Corbett CR. Treatment of varicose veins: the present
and the future–a questionnaire survey. Ann R Coll Surg Engl 2008;90:
561-4.
4. Thakur B, Shalhoub J, Hill AM, Gohel MS, Davies AH. Heterogeneity
in randomised clinical trials of endovenous interventions for varicose
veins. Eur J Vasc Endovasc Surg 2010;40:528-33.
5. Goldman MP. Closure of the greater saphenous vein with endoluminal
radiofrequency thermal heating of the vein wall in combination with
ambulatory phlebectomy: preliminary 6-month follow-up. Dermatol
Surg 2000;26:452-6.
6. Min RJ, Zimmet SE, Isaacs MN, Forrestal MD. Endovenous laser
treatment of the incompetent greater saphenous vein. J Vasc Interv
Radiol 2001;12:1167-71.
7. Navarro L,Min RJ, BoneC. Endovenous laser: a newminimally invasive
method of treatment for varicose veins–preliminary observations using
an 810-nm diode laser. Dermatol Surg 2001;27:117-22.8. Kulkarni SR, Barwell JR, Gohel MS, Bulbulia RA, Whyman MR,
Poskitt KR. Residual venous reflux after superficial venous surgery
2does not predict ulcer recurrence. Eur J Vasc Endovasc Surg 2007;
34:107-11.
9. Vasquez MA, Munschauer CE. Venous clinical severity score and
quality-of-life assessment tools: application to vein practice. Phlebology
2008;23:259-75.
0. Van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T.
Endovenous therapies of lower extremity varicosities: a meta-analysis. J
Vasc Surg 2009;49:230-9.
1. Gohel MS, Barwell JR, Earnshaw JJ, Heather BP, Mitchell DC, Why-
man MR, et al. Randomized clinical trial of compression plus surgery
versus compression alone in chronic venous ulceration (ESCHAR
study)–haemodynamic and anatomical changes. Br J Surg 2005;92:
291-7.
2. Kundu S, Lurie F, Millward SF, Padberg F Jr, Vedantham S, Elias S, et
al. Recommended reporting standards for endovenous ablation for the
treatment of venous insufficiency: joint statement of the American
Venous Forum and the Society of Interventional Radiology. J Vasc Surg
2007;46:582-9.
3. Kundu S, Lurie F, Millward SF, Padberg F Jr, Vedantham S, Elias S, et
al. Recommended reporting standards for endovenous ablation for the
treatment of venous insufficiency: joint statement of the American
Venous Forum and the Society of Interventional Radiology. J Vasc
Interv Radiol 2009;20(7 Suppl):S417-24.
4. Black N, Jenkinson C. How can patients’ views of their care enhance
quality improvement. BMJ 2009;339:202-5.
5. Shepherd AC, Gohel MS, Brown LC, Metcalfe MJ, Hamish M, Davies
AH. Randomized clinical trial of VNUS ClosureFAST radiofrequency
ablation versus laser for varicose veins. Br J Surg 2010;97:810-8.
6. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner
MH, Moneta GL. Venous severity scoring: an adjunct to venous
outcome assessment. J Vasc Surg 2000;31:1307-12.
7. Garratt AM, Macdonald LM, Ruta DA, Russell IT, Buckingham JK,
Krukowski ZH. Towards measurement of outcome for patients with
varicose veins. Qual Health Care 1993;2:5-10.
8. Smith JJ, Garratt AM, Guest M, Greenhalgh RM, Davies AH. Evalu-
ating and improving health-related quality of life in patients with
varicose veins. J Vasc Surg 1999;30:710-9.
9. Guex JJ, Zimmet SE, Boussetta S, Nguyen C, Taieb C. Construction
and validation of a patient-reported outcome dedicated to chronic
venous disorders: SQOR-V (specific quality of life and outcome re-
sponse  venous). J Mal Vasc 2007;32:135-47.
0. Garratt AM, Ruta DA, Abdalla MI, Russell IT. Responsiveness of the
SF-36 and a condition-specific measure of health for patients with
varicose veins. Qual Life Res 1996;5:223-34.
1. MacKenzie RK, Allan PL, Ruckley CV, Bradbury AW. The effect of
long saphenous vein stripping on deep venous reflux. Eur J Vasc
Endovasc Surg 2004;28:104-7.
2. Mackenzie RK, Lee AJ, Paisley A, Burns P, Allan PL, Ruckley CV, et al.
Patient, operative, and surgeon factors that influence the effect of
superficial venous surgery on disease-specific quality of life. J Vasc Surg
2002;36:896-902.
3. Darwood RJ, Theivacumar N, Dellagrammaticas D, Mavor AI, Gough
MJ. Randomized clinical trial comparing endovenous laser ablation
with surgery for the treatment of primary great saphenous varicose
veins. Br J Surg 2008;95:294-301.
4. Rasmussen LH, Bjoern L, LawaetzM, Blemings A, Lawaetz B, Eklof B.
Randomized trial comparing endovenous laser ablation of the great
saphenous vein with high ligation and stripping in patients with varicose
veins: short-term results. J Vasc Surg 2007;46:308-15.
5. Darvall KA, SamRC, Bate GR, AdamDJ, Silverman SH, Bradbury AW.
Photoplethysmographic venous refilling times following ultrasound
guided foam sclerotherapy for symptomatic superficial venous reflux:
relationship with clinical outcomes. Eur J Vasc Endovasc Surg 2010;
40:267-72.
6. Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG. What
are the symptoms of varicose veins? Edinburgh vein study cross sectional
population survey. BMJ 1999;318:353-6.7. TheivacumarNS, Dellagrammaticas D, Darwood RJ,Mavor AI, Gough
MJ. Fate of the great saphenous vein following endovenous laser
33
JOURNAL OF VASCULAR SURGERY
February 2011382 Shepherd et alablation: does re-canalisation mean recurrence? Eur J Vasc Endovasc
Surg 2008;36:211-5.
28. MarstonWA, Brabham VW,Mendes R, Berndt D, Weiner M, Keagy B.
The importance of deep venous reflux velocity as a determinant of
outcome in patients with combined superficial and deep venous reflux
treated with endovenous saphenous ablation. J Vasc Surg 2008;48:
400-5; Discussion 405-6.
29. Campbell WB, Decaluwe H, Boecxstaens V, MacIntyre JA, Walker N,
Thompson JF, et al. The symptoms of varicose veins: difficult to0. Guex JJ. Patient-reported outcome or physician-reported outcome?
Phlebology 2008;23:251.
1. Smith SC, Cano S, LampingDS, Staniszewska S, Browne J, Lewsey J, et
al. Patient-reported outcome measures (PROMs) for routine use in
Treatment Centres: recommendations based on a review of the scien-
tific evidence. London, UK: Health Services Research Unit, London
School of Hygiene and Tropical Medicine; 2005; Final report to the
Department of Health.determine and difficult to study. Eur J Vasc Endovasc Surg 2007;34:
741-4. Submitted Jul 18, 2010; accepted Sep 8, 2010.
